As expected Australia-based medical device company dorsaVi has received a new FDA 510(k) that expands the use case for the suite of wearable sensors, called ViMove, to allow providers to use them for tracking additional static postures like a natural standing posture and various sitting postures. The new clearance also enables providers to use the devices to track healthy patients and establish a...
An FDA-cleared clinical grade activity tracking system has come to the US for use in workplace injury prevention. The ViSafe system, from Australian company dorsaVi, has previously been deployed in Australia and the UK in fields ranging from retail to mining.
"It’s our goal to reduce movement-related risk during the work task and we want to make workplace environments safer,"dorsaVi US president...
Camntech's MotionWatch
In February of this year, the FDA cleared two wristworn activity trackers from British company Camntech: non-smartphone-connected, but highly accurate devices intended for use in clinical trials. In July, Australian company dorsaVi followed suit, obtaining clearance for its ViMove sensor system for detailed activity tracking. Meanwhile, Orthocare Innovations, a company...
Australian company dorsaVi has received FDA clearance for its ViMove sensor system. The sensor tracks movement as well as muscle activation, and is intended to be used in a clinical setting or with athletes in training.
Despite the preponderance of consumer fitness trackers, FDA-cleared devices for tracking movement in the clinical sphere are just starting to emerge, partly because of the...
